Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An announcement from Pharmacorp Rx Inc. ( (TSE:PCRX) ) is now available.
PharmaCorp Rx Inc. has announced a definitive agreement to acquire a pre-1954 charter company in Ontario for $2,090,000. This strategic acquisition will allow PharmaCorp to own and operate pharmacies across Ontario, overcoming regulatory restrictions that prevent non-pharmacist-owned corporations from operating pharmacies in the region. This move is expected to facilitate PharmaCorp’s growth in the Ontario market, enhancing its industry positioning and providing new opportunities for expansion.
More about Pharmacorp Rx Inc.
PharmaCorp Rx Inc. operates in the pharmaceutical industry, focusing on acquiring and operating pharmacies. The company currently manages three PharmaChoice bannered pharmacies in Canada and aims to expand its portfolio by acquiring both PharmaChoice Canada branded and independently owned pharmacies. PharmaCorp’s shares are traded on the TSX Venture Exchange under the symbol PCRX.
YTD Price Performance: 11.36%
Average Trading Volume: 23,586
Technical Sentiment Signal: Sell
Current Market Cap: C$53.56M
For a thorough assessment of PCRX stock, go to TipRanks’ Stock Analysis page.